Riskpilot← Back to searchSign inGet full accessSOLAPSYKOLOGENE AS
ASActiveOrg 919165421Rådhusvegen 30, 4050 SolaActivities of psychologists and psychotherapists, except medical doctors · NACE 8693Est. 20170 employeeswww.solapsykologene.no
Revenue 2024
NOK 6,8M
-14% vs 2023
EBITDA margin
4.7%
+321% vs 2023
Equity ratio
71.4%
Financial strength
Net profit 2024
NOK 245K
+344% vs 2023
| Revenue | NOK 6,8M | -14% |
| EBITDA | NOK 321K | +321% |
| Net profit | NOK 245K | +344% |
| Total assets | NOK 733K | -27% |
| Equity | NOK 523K | +71% |
| Employees | 0 | — |
Legal name
SOLAPSYKOLOGENE AS
Org number
919165421
Legal form
Aksjeselskap
NACE code
8693 · Activities of psychologists and psychotherapists, except medical doctors
Founded
21. juni 2017
Share capital
NOK 32 100
Employees
0
VAT registered
No
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets medlemmer hver for seg.
Company purpose
Fremme psykisk helse og annet som naturlig faller sammen med dette.
Address
Rådhusvegen 30, 4050 Sola
Website
www.solapsykologene.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 45 | 885 | 1 508 | 2 308 | 3 130 | 4 168 | 7 977 | 6 849 |
| Staff expenses | −0 | −0 | −0 | −0 | −0 | −0 | −0 | −40 |
| EBITDA | −25 | −29 | 31 | 102 | 43 | 244 | 76 | 321 |
| Depreciation & amort. | −0 | −0 | −0 | −0 | −0 | −0 | −5 | −5 |
| EBIT | −25 | −29 | 31 | 102 | 43 | 244 | 71 | 316 |
| Net financials | 0 | 1 | 0 | −0 | 0 | 0 | −0 | −2 |
| Profit before tax | −25 | −28 | 31 | 101 | 43 | 244 | 71 | 314 |
| Tax | −0 | −0 | −0 | 17 | 15 | 48 | 16 | 69 |
| Net profit | −25 | −28 | 31 | 84 | 28 | 196 | 55 | 245 |
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|
| Total assets | 91 | 63 | 221 | 215 | 367 | 526 | 1 006 | 733 |
| Equity | −0 | −28 | 3 | 87 | 115 | 371 | 306 | 523 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 92 | 91 | 219 | 128 | 252 | 155 | 700 | 209 |
| Total debt | 92 | 91 | 219 | 128 | 252 | 155 | 700 | 209 |
EBITDA margin
4.7%
This company
15.8%
Market median
-70% vs market
20172024
Equity ratio
71.4%
This company
38.2%
Market median
+87% vs market
20172024
Return on equity
46.8%
This company
18.4%
Market median
+154% vs market
20172024
Net profit margin
3.6%
This company
8.1%
Market median
-56% vs market
20172024
Asset turnover
9.35×
This company
1.12×
Market median
+735% vs market
20172024
Debt / equity
0.40×
This company
0.62×
Market median
+35% vs market
20172024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
- Annual report 2019Filed via Brønnøysundsregistrene · Period 2019-01-01 – 2019-12-31
- Annual report 2018Filed via Brønnøysundsregistrene · Period 2018-01-01 – 2018-12-31
- Annual report 2017Filed via Brønnøysundsregistrene · Period 2017-06-07 – 2017-12-31
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
CK Chief Executive Officer | Chief Executive Officer | 2024 | — | — |
FG Chief Executive Officer | Chief Executive Officer | 2019 | — | — |
| Name | Role | Member since | Age | Other directorships |
|---|---|---|---|---|
| Chairman | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2022 | — | — | |
| Board of Directors | 2021 | — | — |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
Solapsykologene As | Company | 30.8% | 30.8% | 2024 |
Psykolog Camilla Melin As | Company | 25.9% | 25.9% | 2024 |
| Individual | 17.7% | 17.7% | 2024 | |
| Individual | 17.7% | 17.7% | 2024 | |
| Individual | 14.7% | 14.7% | 2022 | |
| Individual | 14.7% | 14.7% | 2022 | |
| Individual | 8.0% | 8.0% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of SOLAPSYKOLOGENE AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Camilla Kristin Melin | Chief Executive Officer | 0 companies |
| Fabiana Gaspar Franco | Chief Executive Officer | 0 companies |
| Thomas Sortland | Chairman | 0 companies |
| Petros Drosos | Board of Directors | 0 companies |
| Peter Strassegger | Board of Directors | 0 companies |
| Sunniva Olivia Rørvik Sandblost | Board of Directors | 0 companies |